Maria Angelica Pabon Porras, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 7 | 2024 | 11653 | 0.750 |
Why?
|
Smoke | 2 | 2018 | 234 | 0.660 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2017 | 48 | 0.600 |
Why?
|
Sex Characteristics | 3 | 2023 | 2633 | 0.510 |
Why?
|
Organ Transplantation | 2 | 2016 | 1154 | 0.500 |
Why?
|
Autophagy | 3 | 2018 | 1319 | 0.470 |
Why?
|
Carcinoma, Basal Cell | 1 | 2016 | 559 | 0.370 |
Why?
|
Stroke Volume | 6 | 2024 | 5487 | 0.370 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2014 | 1355 | 0.360 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2011 | 293 | 0.360 |
Why?
|
Peripheral Arterial Disease | 1 | 2022 | 1271 | 0.360 |
Why?
|
Lung Diseases | 2 | 2016 | 1909 | 0.330 |
Why?
|
Biphenyl Compounds | 2 | 2024 | 1003 | 0.300 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.270 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2024 | 1031 | 0.270 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3202 | 0.270 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1925 | 0.260 |
Why?
|
Graft vs Host Disease | 2 | 2014 | 3028 | 0.240 |
Why?
|
Pre-Eclampsia | 2 | 2024 | 1229 | 0.230 |
Why?
|
Graft Rejection | 2 | 2014 | 4438 | 0.230 |
Why?
|
Pericarditis | 1 | 2024 | 134 | 0.210 |
Why?
|
Critical Illness | 4 | 2018 | 2722 | 0.200 |
Why?
|
Ankle Brachial Index | 1 | 2022 | 163 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4020 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 932 | 0.180 |
Why?
|
Natriuretic Peptides | 1 | 2022 | 155 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 557 | 0.180 |
Why?
|
Kidney Transplantation | 2 | 2014 | 4226 | 0.180 |
Why?
|
Complement Factor D | 1 | 2019 | 66 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15476 | 0.170 |
Why?
|
Complement C3a | 1 | 2019 | 66 | 0.170 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.170 |
Why?
|
Republic of Korea | 2 | 2018 | 571 | 0.160 |
Why?
|
Coronary Circulation | 1 | 2024 | 1565 | 0.150 |
Why?
|
Hypotension | 1 | 2024 | 879 | 0.150 |
Why?
|
Drug Combinations | 1 | 2024 | 2043 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 517 | 0.150 |
Why?
|
Vasodilator Agents | 1 | 2022 | 973 | 0.140 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 140 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2016 | 5815 | 0.140 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3876 | 0.130 |
Why?
|
Iron-Binding Proteins | 1 | 2016 | 79 | 0.130 |
Why?
|
Multiple Organ Failure | 1 | 2018 | 386 | 0.130 |
Why?
|
Bronchitis | 1 | 2016 | 196 | 0.120 |
Why?
|
Exercise Therapy | 1 | 2022 | 925 | 0.120 |
Why?
|
Sunlight | 1 | 2016 | 337 | 0.120 |
Why?
|
Iron Chelating Agents | 1 | 2016 | 141 | 0.120 |
Why?
|
Chemoprevention | 1 | 2016 | 326 | 0.120 |
Why?
|
Mitochondria | 2 | 2018 | 3624 | 0.110 |
Why?
|
Obesity | 1 | 2016 | 12918 | 0.110 |
Why?
|
Placenta | 1 | 2023 | 1704 | 0.110 |
Why?
|
Humans | 24 | 2024 | 760437 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2117 | 0.100 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 869 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 898 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2082 | 0.100 |
Why?
|
Pregnancy Outcome | 1 | 2023 | 2916 | 0.100 |
Why?
|
H-Y Antigen | 1 | 2011 | 42 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.100 |
Why?
|
Fibrosis | 1 | 2018 | 2048 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1957 | 0.090 |
Why?
|
Histocompatibility | 1 | 2011 | 317 | 0.090 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 685 | 0.090 |
Why?
|
Propensity Score | 1 | 2017 | 1906 | 0.090 |
Why?
|
Female | 12 | 2024 | 391875 | 0.090 |
Why?
|
ROC Curve | 1 | 2017 | 3571 | 0.090 |
Why?
|
Histocompatibility Testing | 1 | 2011 | 719 | 0.090 |
Why?
|
Hospital Mortality | 3 | 2018 | 5283 | 0.080 |
Why?
|
Risk Factors | 5 | 2024 | 74055 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1886 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2024 | 4168 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5790 | 0.080 |
Why?
|
Sex Factors | 1 | 2022 | 10538 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2018 | 3742 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3108 | 0.070 |
Why?
|
Iron | 1 | 2016 | 1787 | 0.070 |
Why?
|
Smoking | 2 | 2022 | 9046 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 29831 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12127 | 0.070 |
Why?
|
Male | 9 | 2024 | 360035 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15820 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3661 | 0.070 |
Why?
|
Logistic Models | 2 | 2018 | 13240 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2018 | 14397 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2018 | 3059 | 0.060 |
Why?
|
Immune Tolerance | 1 | 2014 | 2300 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9410 | 0.060 |
Why?
|
Cell Line | 1 | 2018 | 15598 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2024 | 64591 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6813 | 0.060 |
Why?
|
Animals | 7 | 2019 | 168253 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5835 | 0.050 |
Why?
|
Kidney | 1 | 2018 | 7046 | 0.050 |
Why?
|
Sepsis | 1 | 2017 | 2583 | 0.050 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 165 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2014 | 2332 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26280 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14661 | 0.050 |
Why?
|
Mice | 4 | 2019 | 81402 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13338 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18216 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8527 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2021 | 6388 | 0.050 |
Why?
|
Graft Survival | 1 | 2011 | 3806 | 0.050 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 319 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22121 | 0.040 |
Why?
|
Aged | 7 | 2024 | 168840 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12976 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22097 | 0.040 |
Why?
|
Models, Biological | 1 | 2016 | 9462 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 574 | 0.040 |
Why?
|
Glucose | 2 | 2022 | 4342 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1269 | 0.040 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 122 | 0.040 |
Why?
|
Tetrazoles | 1 | 2024 | 907 | 0.040 |
Why?
|
Glycosylation | 1 | 2021 | 1097 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2011 | 2241 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1589 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 220382 | 0.040 |
Why?
|
Rheumatic Diseases | 1 | 2024 | 648 | 0.040 |
Why?
|
Lung | 1 | 2016 | 9973 | 0.040 |
Why?
|
Postpartum Period | 1 | 2024 | 1172 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2017 | 61 | 0.030 |
Why?
|
APACHE | 1 | 2017 | 267 | 0.030 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2016 | 42 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 916 | 0.030 |
Why?
|
Mucociliary Clearance | 1 | 2016 | 80 | 0.030 |
Why?
|
Electron Transport Complex IV | 1 | 2016 | 190 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2016 | 293 | 0.030 |
Why?
|
Prognosis | 2 | 2017 | 29551 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1824 | 0.030 |
Why?
|
Iron, Dietary | 1 | 2016 | 148 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15257 | 0.030 |
Why?
|
Airway Remodeling | 1 | 2016 | 133 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23397 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1807 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1604 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2016 | 696 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 877 | 0.030 |
Why?
|
United States | 2 | 2018 | 72202 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3088 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2517 | 0.020 |
Why?
|
Emergencies | 1 | 2018 | 1217 | 0.020 |
Why?
|
Lung Injury | 1 | 2016 | 422 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1371 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1967 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80430 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3800 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2647 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8479 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6475 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9639 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2019 | 3956 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10075 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5865 | 0.020 |
Why?
|
Insulin | 1 | 2019 | 6591 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12054 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2023 | 58859 | 0.010 |
Why?
|
Pneumonia | 1 | 2016 | 2140 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10698 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9468 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11070 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12932 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8216 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13484 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54339 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2017 | 7860 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23953 | 0.010 |
Why?
|
Adult | 1 | 2024 | 220781 | 0.010 |
Why?
|